Nicotine is an addictive substance found in all tobacco products. In addition to being addictive, it is poisonous. Nicotine is a tertiary amine composed of pyridine and a pyrrolidine ring. It is metabolized primarily by the enzyme CYP2A6, and variation in the rate of nicotine metabolism contributes to differences in vulnerability to tobacco dependence and the response to smoking-cessation treatment. Low doses of nicotine can act as a central nervous system stimulant.
Nicotine can be expected to remain in the blood at significant levels for six to eight hours after the smoking stopped. Regular use of nicotine-containing products will result in physical withdrawal symptoms resembling amphetamine and cocaine dependency. It causes erectile dysfunction (males), heart disease, lung disease, chronic obstructive pulmonary disease (COPD), and certain eye disease. Nicotine addiction has a male predominance. Globally, about 40% of men smoke as compared with nearly 9% of women.
Get FREE sample copy at:
https://www.delveinsight.com/sample-request/nicotine-addiction-market
The Nicotine Addiction market report also covers emerging drugs, current treatment practices, Nicotine Addiction market share of the individual therapies, current and forecasted Nicotine Addiction Market Size from 2017 to 2030 segmented by seven major markets.
The report provides a detailed current Nicotine Addiction treatment practice/algorithm, market drivers, market barriers and unmet medical needs to curate best of the opportunities and assesses the underlying potential of the market.
Nicotine Addiction Market Key Facts
As per the CDC, ‘Cigarette smoking is responsible for more than 480,000 deaths per year in the United States, including more than 41,000 deaths resulting from secondhand smoke exposure. This is about one in five deaths annually, or 1,300 deaths every day’.
Worldwide, tobacco use causes nearly 6 million deaths per year, and current trends show that tobacco use will cause more than 8 million deaths annually by 2030.
In 2016, the prevalence of current cigarette smoking among adults was 15.5%, which was a significant decline from 2005 (20.9%); however, no significant change has occurred since 2015 (15.1%)
According to WHO, “Of the more than 5 million people who die every year from tobacco use, approximately 1.5 million are women”. Unless urgent action is taken, tobacco use could kill up to 8 million people every year by 2030, of which 2.5 million would be women.
Key Benefits of Nicotine Addiction Market Report
-
Nicotine Addiction market report provides an in-depth analysis of Nicotine Addiction Market Size, Share, Trend, Epidemiology and Market Forecast till 2030, in 7 major market i.e. EU5 (Germany, Italy, Spain, France and the UK), Japan, and the United States.
-
The Nicotine Addiction market report will help in developing business strategies by understanding the Nicotine Addiction Market trends & developments, key players and future market competition that will shape and drive the Nicotine Addiction market in the upcoming years.
-
The Nicotine Addiction market report covers Nicotine Addiction current treatment practices, emerging drugs, market share of the individual therapies in 7 MM.
-
The report provides a detailed assessment of the Nicotine Addiction market in terms of market drivers & barriers, Unmet Needs, market opportunities, patient population, comparative analysis of pipeline products with detailed clinical profiles, and other factors.
Nicotine Addiction Market
Owing to the launch of upcoming therapies, the Nicotine Addiction market size shall increase during the forecast period.
The Nicotine Addiction market outlook section of the report helps to build the detailed comprehension of the historic, current and forecasted Nicotine Addiction market trends by analyzing the impact of current therapies on the market, unmet needs, drivers and barriers and demand for better technology.
The report gives a thorough detail of Nicotine Addiction market trend of each marketed drug and late-stage pipeline therapy by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, and view of the key opinion leaders.
Nicotine Addiction Epidemiology
The Nicotine Addiction epidemiology section covers insights about historical and current Nicotine Addiction patient pool and forecasted trends for every seven major countries (i.e. the United States, EU5 countries (Germany, Spain, Italy, France, and the United Kingdom), and Japan from 2017 to 2030.
It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides the diagnosed patient pool and their trends along with assumptions undertaken.
Nicotine Addiction Drugs Uptake and Key Market Players
The Nicotine Addiction Drugs Uptake section focuses on the rate of uptake of the potential drugs recently launched in the Nicotine Addiction market or expected to get launched in the market during the study period. The analysis covers Nicotine Addiction market uptake by drugs; patient uptake by therapies; and sales of each drug.
Report’s Drugs Uptake section helps in understanding the drugs with the most rapid uptake, reasons behind the maximal use of new drugs and allow the comparison of the drugs on the basis of market share and size which again will be useful in investigating factors important in market uptake and in making financial and regulatory decisions.
Some of the key companies in the Nicotine Addiction market include:
GlaxoSmithKline
Pfizer
Omeros Corporation
And many others
Nicotine Addiction therapies covered in the report include:
OMS405
Zyban
Chantix
And many more.
Table of Content
1. Key Insights
2. Executive Summary
3. Nicotine Addiction Competitive Intelligence Analysis
4. Nicotine Addiction Market Overview at a Glance
5. Nicotine Addiction Disease Background and Overview
6. Nicotine Addiction Patient Journey
7. Nicotine Addiction Epidemiology and Patient Population
8. Nicotine Addiction Treatment Algorithm, Current Treatment, and Medical Practices
9. Nicotine Addiction Unmet Needs
10. Key Endpoints of Nicotine Addiction Treatment
11. Nicotine Addiction Marketed Products
12. Nicotine Addiction Emerging Therapies
13. Nicotine Addiction Seven Major Market Analysis
14. Attribute Analysis
15. Nicotine Addiction Market Outlook (7 major markets)
16. Nicotine Addiction Access and Reimbursement Overview
17. KOL Views on the Nicotine Addiction Market.
18. Nicotine Addiction Market Drivers
19. Nicotine Addiction Market Barriers
20. Appendix
21. DelveInsight Capabilities
22. Disclaimer
Related Reports
Nicotine Addiction Epidemiology Forecast
DelveInsight's 'Nicotine Addiction Epidemiology Forecast to 2030' report delivers an in-depth understanding of the disease, historical and forecasted Nicotine Addiction epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.
Nicotine Addiction Pipeline Insights
Nicotine Addiction Pipeline Insight, 2020 report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across the Nicotine Addiction market.
About DelveInsight
DelveInsight is a leading Business Consultant, and Market Research Firm focused exclusively on life sciences. It supports pharma companies by providing end to end comprehensive solutions to improve their performance.
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Shruti Thakur
Email:Send Email
Phone: +919650213330
Address:304 S. Jones Blvd. 2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/
